🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.090
-0.230 (-17.42%)
At close: Nov 20, 2026, 4:00 PM EST
1.050
-0.040 (-3.67%)
After-hours: Nov 20, 2026, 7:59 PM EST

Marker Therapeutics Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Marker Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.87. The average 1-year stock price forecast is 621.74% higher than the current stock price, while the lowest is $5.60 (+413.76%) and the highest is $10 (+817.43%).

Price Target: $7.87 (+621.74%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.60$7.87$8.00$10
Change+413.76%+621.74%+633.94%+817.43%

Analyst Ratings

The average analyst rating for Marker Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy333333
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$10
BuyReiterates$10+817.43%Nov 19, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$8
BuyReiterates$8+633.94%Oct 20, 2026

Financial Forecast

Revenue This Year
4.09M
from 3.55M
Increased by 15.22%
Revenue Next Year
22.02M
from 4.09M
Increased by 438.82%
EPS This Year
-0.50
from -0.76
EPS Next Year
-0.36
from -0.50
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.24M3.51M3.31M6.59M3.55M4.09M
Revenue Growth
166.01%182.96%-5.76%99.06%-46.19%15.22%
Operating Income
-39.48M-19.79M-14.58M-11.12M-12.44M-10.39M
Net Income
-41.88M-29.93M-8.24M-10.73M-12.16M-9.93M
EPS
-----0.76-0.50
Free Cash Flow
-----12.01M-8.20M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.2M
Avg4.1M
Low4.0M

Revenue Growth

Revenue Growth202620272028
High
17.7%
Avg
15.2%
Low
12.8%

EPS Forecast

EPS202620272028
High-0.48
Avg-0.50
Low-0.51

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-